For example, one SCLC subtype is linked to better responses to immunotherapy, which doesn’t work for every patient. And sometimes patients diagnosed with NSCLC find that their tumors evade treatment ...

However, recent data suggests that analyzing the activity of certain proteins called transcription factors (TF) may help distinguish SCLC subtypes. Unfortunately, methods to study these TF profiles ...

Defining a new lung cancer subtype: Atypical small cell carcinoma. Small cell lung cancer (SCLC) is relatively rare to begin with, accounting for 10% to 15% of all lung cancers, according to the ...

The Phase II trial will compare progression-free survival in lung cancer patients treated according to their molecular subtypes.

“Small-cell lung cancer (SCLC), accounting for around 13% of all lung cancers, often results in rapid tumor growth, early metastasis, and acquired therapeutic resistance,” the researchers wrote.

Small cell lung cancer (SCLC) often metastasizes to the brain and has poor prognosis. SCLC subtypes distinguished by expressing transcriptional factors ASCL1 or NEUROD1 have been identified. This ...

Lung cancer is a complex disease comprising various subtypes. A person who receives a diagnosis of SCLC may want to get a second opinion to confirm the diagnosis and offer reassurance about their ...

The facts on small-cell lung cancer, or SCLC, and non-small-cell lung cancer, or NSCLC, like symptoms, prognosis, treatment, and recovery.